|Bid||0.00 x 800|
|Ask||0.00 x 1100|
|Day's Range||102.48 - 103.79|
|52 Week Range||72.88 - 115.49|
|Beta (5Y Monthly)||0.39|
|PE Ratio (TTM)||17.12|
|Earnings Date||Apr 27, 2023|
|Forward Dividend & Yield||2.92 (2.73%)|
|Ex-Dividend Date||Mar 14, 2023|
|1y Target Est||117.52|
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.
Pfizer (PFE), Merck (MRK), Eli Lilly (LLY) and others report fourth-quarter results. An appeals court dismisses J&J's (JNJ) bankruptcy filing related to its talc lawsuits.
RAHWAY, N.J., February 03, 2023--Merck’s KEYTRUDA Plus Chemotherapy Met Primary Endpoint of PFS as First-Line Therapy for Advanced or Recurrent Endometrial Carcinoma